Tab Application Banner
  • Users Online: 549
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2022| June  | Volume 17 | Issue 2  
    Online since June 13, 2022

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLES
Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial
Aryan Mohamadfatih Jalal, Sheelan Faroz Aref, Dashty Abbas Albustany
June 2022, 17(2):136-141
DOI:10.4103/injr.injr_264_21  
  4,235 140 -
LETTERS TO EDITOR
Vaccine hesitancy in patients with autoimmune diseases: Data from the coronavirus disease-2019 vaccination in autoimmune diseases study
Parikshit Sen, James B Lilleker, Vishwesh Agarwal, Sinan Kardes, Marcin Milchert, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O'Callaghan, Elena Nikiphorou, Ai Lyn Tan, Lorenzo Cavagna, Miguel A Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Giovanni Cagnotto, Arvind Nune, Oliver Distler, Hector Chinoy, Rohit Aggarwal, Latika Gupta
June 2022, 17(2):188-191
DOI:10.4103/injr.injr_221_21  
  2,668 151 -
Herpes zoster reactivation after COVID-19 vaccination in patients with autoimmune diseases
Srinivasan Sanjay, Deepika Ponnuru, Sharath Kumar, Vijay K R Rao, Ankush Kawali, Padmamalini Mahendradas
June 2022, 17(2):216-221
DOI:10.4103/injr.injr_137_21  
  2,446 142 -
IMAGES IN RHEUMATOLOGY
IgA vasculitis post-ChAdOx1 nCoV-19 vaccine in a patient with rheumatoid arthritis
Kunal Chandwar, Digvijay Gajanan Ekbote, Juhi Dixit, Kriti Kishor, Kiran Preet Malhotra, Urmila Dhakad
June 2022, 17(2):186-187
DOI:10.4103/injr.injr_205_21  
  2,308 123 -
ORIGINAL ARTICLES
Therapeutic drug monitoring of mycophenolate mofetil for the treatment of pediatric lupus nephritis: A cross-sectional study
Navamani Kirubakaran, Anu Punnen, Ratna Prabha, Indira Agarwal, Sathish Kumar
June 2022, 17(2):124-128
DOI:10.4103/injr.injr_130_21  
  2,086 244 -
Individuals with reactive arthritis suffer from poor health-related quality of life akin to individuals with ankylosing spondylitis: A multigroup study
Prakash Gupta, Rajat Kharbanda, Maryam Abbasi, Roma Raj, Latika Gupta
June 2022, 17(2):110-117
DOI:10.4103/injr.injr_223_21  
  2,115 212 -
CASE BASED REVIEW
Sacroiliitis as presenting manifestation in immune-mediated inflammatory disorders other than spondyloarthritis: Case series and review of literature
Kunal Chandwar, Kriti Kishor, PM Ankush, Mukesh Kumar Maurya, Puneet Kumar, Urmila Dhakad
June 2022, 17(2):174-179
DOI:10.4103/injr.injr_246_21  
  2,148 148 -
ORIGINAL ARTICLES
Experience with macrophage activation syndrome associated with systemic lupus erythematosus: A single-center study from Pakistan
Saira Elaine Anwer Khan, Roshila Shamim, Asadullah Khan, Shabnam Batool, Muhammad Zeeshan Aslam
June 2022, 17(2):118-123
DOI:10.4103/injr.injr_230_21  
  2,012 192 -
CASE BASED REVIEW
Infliximab in treatment of refractory multisystem inflammatory syndrome in children with severe cardiac dysfunction
Guruprasad Hassan Shankar, Jitendra S Oswal, Bhakti U Sarangi, Ajay Walimbe, Prithvichandra Markal, Karthik V Badarayan
June 2022, 17(2):166-169
DOI:10.4103/injr.injr_21_21  
  2,014 157 -
EDITORIAL
Coronavirus disease 2019 infection and autoimmunity: We see only a tip of the iceberg
R Naveen
June 2022, 17(2):107-109
DOI:10.4103/injr.injr_113_22  
  1,593 232 -
ORIGINAL ARTICLES
Effects of fibromyalgia syndrome in patients with diffuse systemic sclerosis: Evaluation with 2010 American college of rheumatology criteria set
Ayse Ayan, Hanife Hale Hekim, Sebahat Yaprak Cetin
June 2022, 17(2):129-135
DOI:10.4103/injr.injr_112_21  
  1,607 176 -
LETTERS TO EDITOR
The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
Kunal Chandwar, Chandani Shah, Puja Srivastava
June 2022, 17(2):193-195
DOI:10.4103/injr.injr_283_21  
  1,540 83 -
The perils of generic small molecules: Has tofacitinib become a toffee
Kunal Chandwar, Prasanna Dogga, Juhi Dixit, Digvijay Gajanan Ekbote, Kriti Kishor
June 2022, 17(2):192-192
DOI:10.4103/injr.injr_204_21  
  1,388 117 -
The emergence of rheumatic immune-mediated inflammatory disease manifestations following SARS-CoV-2 vaccination
Arvind Nune, Hem Raj Sapkota, Karthikeyan P Iyengar
June 2022, 17(2):214-215
DOI:10.4103/injr.injr_145_21  
  1,252 140 -
ORIGINAL ARTICLES
Human leukocyte antigen-B alleles in spondyloarthritides: A single-center, prospective, cross-sectional study
Jeet Hemantkumar Patel, Ved Chaturvedi, Lalit Duggal, Neeraj Jain, Gurbir Bhandari, Monika Jain
June 2022, 17(2):142-148
DOI:10.4103/injr.injr_296_20  
  1,301 91 -
BRIEF REPORTS
Coronavirus Disease-19 associated arthritis – An observational study
Debanjali Sinha, Sumantro Mondal, Alakendu Ghosh
June 2022, 17(2):153-156
DOI:10.4103/injr.injr_133_21  
  1,216 104 -
LETTERS TO EDITOR
Is T-helper 17 inhibition the knight in shining armor we were looking for? Comments on the article by shumy et al.
Kunal Chandwar, Chandani J Shah, Puja Srivastava
June 2022, 17(2):196-198
DOI:10.4103/injr.injr_69_22  
  1,216 74 -
BOOK REVIEW
How to practice academic medicine and publish from developing countries? A practical guide
Madhuri H Radhakrishna, Vinod Ravindran
June 2022, 17(2):222-223
DOI:10.4103/injr.injr_2_22  
  1,158 99 -
REVIEW ARTICLE
Arterial stiffness in rheumatoid arthritis: Current knowledge and future perspectivess
Panagiota Anyfanti, Eleni Bekiari, Elena Angeloudi, Eleni Pagkopoulou, George D Kitas, Theodoros Dimitroulas
June 2022, 17(2):157-165
DOI:10.4103/injr.injr_254_21  
  1,155 99 -
LETTERS TO EDITOR
Granulomatosis with polyangiitis and COVID-19 pneumonia
Arvind Nune, Karthikeyan P Iyengar, D Mulherin, Pranav Ish, CA Musat, Hem Raj Sapkota
June 2022, 17(2):210-212
DOI:10.4103/injr.injr_235_21  
  1,146 105 -
New-onset henoch–Schonlein purpura after COVID-19 vaccination
Rija Mathew Roy, Anna Mani, Joseph John, Thomas Antony, Lydia Jacob
June 2022, 17(2):206-207
DOI:10.4103/injr.injr_226_21  
  1,104 104 -
BOOK REVIEW
Glucocorticoids in rheumatology
Shrikant Wagh
June 2022, 17(2):224-224
DOI:10.4103/injr.injr_20_22  
  1,058 114 -
CASE BASED REVIEW
Bacillus calmette–Guérin scar inflammation after COVID vaccination
BN Shiva Prasad
June 2022, 17(2):170-173
DOI:10.4103/injr.injr_194_21  
  1,032 105 -
LETTERS TO EDITOR
Unilateral retinopathy in a case of systemic lupus erythematosus
Pradeep Kumar Panigrahi, Lipika Mehra
June 2022, 17(2):202-203
DOI:10.4103/injr.injr_244_21  
  1,055 77 -
CASE BASED REVIEW
Childhood-onset enthesitis-related arthritis leading to nephrotic syndrome due to secondary amyloidosis complicated by acute pulmonary embolism - The domino effect
Vishal Mangal, Bhaskar Datt, Arun Hegde, AW Kashif, Ankit Kumar, Jaspreet Kaur, Nidhi Goel, Anil Shankar Menon
June 2022, 17(2):180-185
DOI:10.4103/injr.injr_160_21  
  979 97 -
BRIEF REPORTS
Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India
Rasmi Ranjan Sahoo, Manesh Manoj, Prashant Bafna, Kasturi Hazarika, Anupam Wakhlu
June 2022, 17(2):149-152
DOI:10.4103/injr.injr_70_21  
  980 85 -
LETTERS TO EDITOR
Anti-synthetase syndrome masquerading as COVID-19
Rajat Kharbanda, Neeraj Jain, Latika Gupta
June 2022, 17(2):208-209
DOI:10.4103/injr.injr_180_21  
  860 74 -
Comment to “Does gender gap exist in indian rheumatology? Analysis of faculty gender representation at its annual conferences” by Mohansundaram et al.
Sahla Sathar, Nivedita Jha, Molly Mary Thabah
June 2022, 17(2):200-201
DOI:10.4103/injr.injr_138_21  
  863 68 -
Hydroxychloroquine in COVID-19 widespread use despite unproven benefit
Pranav Ish
June 2022, 17(2):213-213
DOI:10.4103/injr.injr_7_22  
  857 71 -
Optimizing corticosteroid therapy in takayasu arteritis
Pallavi Patro
June 2022, 17(2):199-199
DOI:10.4103/injr.injr_41_22  
  822 72 -
Assessing the risk of retinopathy in indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study – Reply
Arindam Nandy Roy, Vinitha Samala, Yarram Ashok Kumar, Syeda Sana Fatima
June 2022, 17(2):204-205
DOI:10.4103/injr.injr_6_21  
  649 68 -